Only One-fifth Of Japanese Medical Societies Have Conflict Of Interest Guidelines
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In an effort to avert unethical and potentially illegal transactions between medical practitioners and pharmaceutical and medical device companies, Japan's medical societies have been trying to introduce conflict of interest guidelines; yet to date, only about one-fifth of the more than 100 societies have issued such standards, according to an official at the Japanese Association of Medical Societies
You may also be interested in...
Japanese Pharma To Beef Up Transparency Policies In 2011 To Counter Public Concern - APEC Regulatory Conference
SEOUL - Japanese pharma agreed to rollout updated in-house transparency guidelines in 2011 to strengthen compliance and improve the industry's public reputation
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).